Search Results for "valganciclovir"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for valganciclovir. Results 1 to 1 of 1 total matches.
See also: Valcyte

Maribavir (Livtencity) for Cytomegalovirus Infection (online only)

   
The Medical Letter on Drugs and Therapeutics • Nov 28, 2022  (Issue 1664)
ganciclovir, oral valganciclovir, IV foscarnet, and IV cidofovir are effective against CMV, but their use ...
Maribavir (Livtencity – Takeda), an oral cytomegalovirus (CMV) pUL97 kinase inhibitor, has been approved by the FDA for treatment of post-transplant CMV infection refractory to standard antiviral therapy in patients ≥12 years old who weigh at least 35 kg.
Med Lett Drugs Ther. 2022 Nov 28;64(1664):e193-4 |  Show IntroductionHide Introduction